Tag: Kidney Problems: Misc.
ASN: eGFR No Different With Sparsentan, Irbesartan in Focal Segmental Glomerulosclerosis
No difference in eGFR slope with sparsentan versus irbesartan among patients with focal segmental glomerulosclerosis
ASN: Multicomponent Intervention Does Not Increase Steps Toward Kidney Transplant
Intervention does not significantly increase the rate of completed steps toward receiving a kidney transplant
Kidney Disease Impacts Weight Loss After Bariatric Surgery
However, magnitude of weight loss difference may not be clinically significant
IDSA: Piperacillin-Tazobactam, Cefepime Comparable for Suspected Infection
Incidence of acute kidney injury or death did not differ among those receiving cefepime and piperacillin-tazobactam
CKD Strongest Risk Factor for Sudden Cardiac Arrest in Hispanics/Latinos
Other risk factors include heavy drinking, stroke, atrial fibrillation, coronary artery disease, heart failure, diabetes
Similar Management Seen for Dialysis-Requiring AKI, ESKD Patients
In recent study, 72 percent of AKI-D patients who recovered discontinued dialysis with no change from the initial prescription
Canagliflozin Reduces Cardiorenal Biomarkers in T2D
Increase in biomarkers and multimarker panel linked to increased risk for primary cardiorenal outcome
Budesonide Yields Durable Reduction in eGFR for IgA Nephropathy
Clinically relevant reduction in eGFR seen over two years with targeted release formulation of budesonide
Improved Outcomes Seen With Lower 2021 KDIGO BP Target
Risk for composite kidney outcome reduced with lower 2021 KDIGO BP target versus 2012 KDIGO target
Higher Plant Protein Intake Tied to Lower Risk for Chronic Kidney Disease
Finding persists whether kidney disease is based on diagnostic code or laboratory measurements
